Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verrica Pharmaceuticals Inc.

0.6231
-0.0507-7.52%
Post-market: 0.6215-0.0016-0.26%16:48 EDT
Volume:128.82K
Turnover:82.40K
Market Cap:57.63M
PE:-0.60
High:0.6812
Open:0.6436
Low:0.6161
Close:0.6738
Loading ...

Verrica Pharmaceuticals Announces Sixth Amendment to Credit Agreement with Lenders

Reuters
·
Yesterday

Verrica Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Reuters
·
06 Jun

Verrica Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in New York City

Reuters
·
28 May

Verrica Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
15 May

Verrica Pharmaceuticals Q1 Adj. EPS $(0.08) Beats $(0.10) Estimate, Sales $3.44M Beat $2.51M Estimate

Benzinga
·
14 May

Verrica Pharmaceuticals Reports Reduced Net Loss of $9.7M and EPS of $0.10 for Q1 2025, Improvement from $20.3M Loss and $0.44 EPS in Q1 2024

Reuters
·
14 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Verrica Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
09 May

Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025

THOMSON REUTERS
·
07 May

Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York

GlobeNewswire
·
30 Apr

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Verrica Pharmaceuticals (VRCA)

TIPRANKS
·
07 Apr

BRIEF-Verrica Pharmaceuticals Reports Strong Demand-Led Growth In Ycanth® In Q1 2025

Reuters
·
07 Apr

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in Ycanth® Dispensed Applicator Units in First Quarter 2025

THOMSON REUTERS
·
07 Apr

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025

GlobeNewswire
·
07 Apr

RBC Capital Sticks to Their Hold Rating for Verrica Pharmaceuticals (VRCA)

TIPRANKS
·
05 Apr

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.d. to Its Board of Directors

THOMSON REUTERS
·
03 Apr

Press Release: Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

Dow Jones
·
03 Apr

Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now

Zacks
·
01 Apr

Press Release: Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer

Dow Jones
·
26 Mar

Verrica Pharmaceuticals Inc (VRCA) Q4 2024 Earnings Call Highlights: Revenue Growth and ...

GuruFocus.com
·
12 Mar